Literature DB >> 11728606

Pharmacology of adenosine receptors in the vasculature.

R Tabrizchi1, S Bedi.   

Abstract

Adenosine is widely distributed in mammals. One of the primary roles of adenosine within the cardiovascular system is to directly control the functions of both cardiac and vascular tissues. Recently, there has been considerable interest in the subclassification of adenosine receptors. Characterization of a heterogeneous population of receptors for adenosine could provide an opportunity for the development of novel compounds of therapeutic value. Adenosine is released from cells as a result of metabolism, and its release can be increased dramatically from cells that are metabolically stressed. This implies that adenosine can be released from a variety of cells throughout the body, as a result of increased metabolic rates, in concentrations that can have a profound impact on blood vessel function and, consequently, blood flow. It is recognized that the actions of this nucleoside on the vasculature are most prominent when oxygen demand is high and there is a reduction in oxygen tension at the site in question. Therefore, it is not surprising that adenosine has been shown to be an important regulator of blood vessel tone under hypoxic conditions. Furthermore, the activation of adenosine receptors on blood vessels can result in relaxation and/or contractions. The nature of the response subsequent to the activation of adenosine receptors is primarily dependent on the type of blood vessel involved and basal tone. This review will focus on the characterization of subtypes of adenosine receptors in blood vessels, as well as the effect of the stimulation of adenosine receptors on the peripheral circulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728606     DOI: 10.1016/s0163-7258(01)00152-8

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  44 in total

1.  Role of ω-hydroxylase in adenosine-mediated aortic response through MAP kinase using A2A-receptor knockout mice.

Authors:  Dovenia S Ponnoth; Mohammed A Nayeem; Swati S Kunduri; Stephen L Tilley; Darryl C Zeldin; Catherine Ledent; S Jamal Mustafa
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-07       Impact factor: 3.619

2.  Chronic mild hyperhomocysteinemia alters ectonucleotidase activities and gene expression of ecto-5'-nucleotidase/CD73 in rat lymphocytes.

Authors:  Emilene B S Scherer; Luiz Eduardo B Savio; Fernanda C Vuaden; Andréa G K Ferreira; Maurício R Bogo; Carla D Bonan; Angela T S Wyse
Journal:  Mol Cell Biochem       Date:  2011-11-02       Impact factor: 3.396

3.  A distinct nitric oxide and adenosine A1 receptor dependent hepatic artery vasodilatatory response in the CCl-cirrhotic liver.

Authors:  Alexander Zipprich; Wajahat Z Mehal; Cristina Ripoll; Roberto J Groszmann
Journal:  Liver Int       Date:  2010-05-24       Impact factor: 5.828

4.  Adenosine receptor inhibition attenuates the suppression of postexercise cutaneous blood flow.

Authors:  Ryan McGinn; Naoto Fujii; Brendan Swift; Dallon T Lamarche; Glen P Kenny
Journal:  J Physiol       Date:  2014-03-31       Impact factor: 5.182

5.  Indirect basal ganglia pathway mediation of repetitive behavior: attenuation by adenosine receptor agonists.

Authors:  Yoko Tanimura; Sasha Vaziri; Mark H Lewis
Journal:  Behav Brain Res       Date:  2010-02-21       Impact factor: 3.332

6.  Differential coronary microvascular exchange responses to adenosine: roles of receptor and microvessel subtypes.

Authors:  Jianjie Wang; Stevan P Whitt; Leona J Rubin; Virginia H Huxley
Journal:  Microcirculation       Date:  2005-06       Impact factor: 2.628

7.  Maternal hypoxia and caffeine exposure depress fetal cardiovascular function during primary organogenesis.

Authors:  Nobuo Momoi; Joseph P Tinney; Bradley B Keller; Kimimasa Tobita
Journal:  J Obstet Gynaecol Res       Date:  2012-05-21       Impact factor: 1.730

8.  Adenosine and its receptors as therapeutic targets: An overview.

Authors:  Sakshi Sachdeva; Monika Gupta
Journal:  Saudi Pharm J       Date:  2012-06-23       Impact factor: 4.330

9.  ST segment elevation during adenosine pharmacological stress testing in a patient with coronary artery disease.

Authors:  Jaffar Ali Raza; Nazim Uddin Azam Khan; Jamal S Mustafa; Assad Movahed
Journal:  Am Heart Hosp J       Date:  2009

Review 10.  G-Protein-Coupled Receptors in Heart Disease.

Authors:  Jialu Wang; Clarice Gareri; Howard A Rockman
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.